Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute, shared a post on LinkedIn։
”During my stay in Lisbon I had a privilege to give a lecture for Polish cardiologists about ‘Anticoagulation in specific situations’ during special pre-ACVC event.
Anticoagulation in real life causes lot of dilemmas, and we are increasingly forced to make individualized decisions and move towards patient-oriented precise medicine.
With Christophe Vandenbriele we wrote last year one of the Association for Acute Cardio Vascular Care – ACVC Clinical Decision Making Toolkit chapters: 10.2 Managing anticoagulation in critically ill in specific situations, which includes i.e. bleeding on OAC, anticagulation and hemolysis during MCS, heparin-induced thrombocytopenia, and MV thrombosis.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering